DRG 266 ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATIONS
DRG 267 ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATIONS
“TAVR Cost & Direct Contribution Margin Analysis”, please provide feedback to the following questions looking at DRG
1) Why is there a difference in cost between DRG 266 & 267?
2) What is direct contribution margin?
3) Is this model profitable? If not, what further information would you need to determine profitability?
What is Transcatheter Aortic Valve Replacement (TAVR)?
